Enabling the Future of Medicine
Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO). We offer technology platforms and services that enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support patients around the world.
Awards & Recognition
2024
Included in S&P Global Sustainability Yearbook 2024
2023
Frost & Sullivan 2023 Global CDRMO Company of the Year
2023
EcoVadis Silver Medal for Sustainability Achievement
2023
Phacilitate Advanced Therapies Awards - Manufacturing Tech Disruptor of the Year
Our Role in the Industry
Advanced Therapies works with hundreds of companies to help them research, discover, test, develop, and manufacture advanced therapeutics that benefit patients. We have always been guided by our core value of “doing the right thing and doing it right.” And we remain committed to this ethos in everything we do.
Our Mission
The mission for Advanced Therapies is to help make safe and effective cell and gene therapies available to patients quickly and efficiently. Our role is to work alongside therapy developers to help them research, discover, analyze, test, develop, and manufacture products that provide an alternative approach to traditional pharmaceutical approaches.
Privacy, Security and Intellectual Property
One of our core business tenets is to ensure and preserve the trust, confidence, and privacy of our customers. We know how integral the intellectual property (IP) that you develop is to your success and competitiveness and safeguarding it has always been of the utmost importance to our company. We have a strong security infrastructure and robust corporate culture that protects the intellectual property and data of our customers and their patients.
Environmental, Social and Governance
As a responsible business, we serve the long-term interest of our stakeholders. Our governance models include a Board of Directors and both a compliance department and audit committee. We strive to protect our planet with established targets for reduction in green-house gas (GHG), energy, and water consumption. We take our social responsibilities seriously and support patient advocacy groups like the Emily Whitehead and Opie Jones Foundations. Furthermore, we also prioritize employee development and diversity and inclusion in the workplace.
Articles & Events
Advanced Therapies Acquired by Altaris
Philadelphia, U.S. and Oxford, U.K. sites and capabilities spun out of WuXi AppTec We are excited to share that Altaris completed its acquisition of Advanced Therapies U.S. and OXGENE (together “Advanced Therapies”) on 7 March 2025. Advanced Therapies is now fully owned by Altaris and headquartered in the United States. Altaris is an investment firm […]
Get in Touch with Us
Our team of experts is available to talk to you about your program's needs, critical milestones and timelines. You can also contact us to learn about career opportunities and more.